Read + Share
Amedeo Smart
Independent Medical Education
Liu CC, Veeraraghavan J, Tan Y, Kim JA, et al. A Novel Neoplastic Fusion Transcript, RAD51AP1-DYRK4, Confers Sensitivity to the MEK Inhibitor Trametinib in Aggressive Breast Cancers. Clin Cancer Res 2021;27:785-798.PMID: 33172895
Email
LinkedIn
Facebook
Twitter
Privacy Policy